| Biomarker ID | 1491 |
| PMID | 25075566 |
| Year | 2014 |
| Biomarker | Interleukin-1β (IL-1β) + Interferon β (IFNβ) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Interleukin-1β (IL-1β): Increased in patients with Biochemical Recurrence; Interferon β (IFNβ): Decreased in patients with Biochemical Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Recurrence Vs No Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | 118 patients with primary prostate cancer (78 without and 40 with recurrence during the follow-up period) were selected |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.004 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |